RSV Vaccine Market To Reach USD 2.2 Billion By 2032 | DataHorizzon Research
18 avr. 2024 06h10 HE
|
DataHorizzon Research
Fort Collins, Colorado, April 18, 2024 (GLOBE NEWSWIRE) -- Growing prevalence of RSV in the population drives the need for RSV vaccines. RSV, a prevalent respiratory virus, often leads to severe...